| Year |
Citation |
Score |
| 2024 |
Desai S, Ahmad S, Bawaskar B, Rashmi S, Mishra R, Lakhwani D, Dutt A. Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome. Nar Cancer. 6: zcae010. PMID 38487301 DOI: 10.1093/narcan/zcae010 |
0.352 |
|
| 2023 |
Chougule A, Chandrani P, Noronha V, Pange P, Kale S, Nikam A, Nambiar K, Marchande D, Durve A, Gupta V, Jagtap V, Tiwrekar P, Menon N, Joshi A, Kaushal R, ... ... Dutt A, et al. Real-World Evidence of EGFR Targeted Therapy in NSCLC- A Brief Report of Decade Long Single Center Experience. Jto Clinical and Research Reports. 4: 100566. PMID 38033811 DOI: 10.1016/j.jtocrr.2023.100566 |
0.345 |
|
| 2022 |
Joshi A, Butle A, Hait S, Mishra R, Trivedi V, Thorat R, Choughule A, Noronha V, Prabhash K, Dutt A. Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation. Translational Oncology. 22: 101461. PMID 35653897 DOI: 10.1016/j.tranon.2022.101461 |
0.367 |
|
| 2021 |
Butle A, Joshi A, Noronha V, Prabhash K, Dutt A. Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs. Translational Oncology. 14: 101111. PMID 33993094 DOI: 10.1016/j.tranon.2021.101111 |
0.305 |
|
| 2020 |
Togar T, Desai S, Mishra R, Terwadkar P, Ramteke M, Ranjan M, Kawle D, Sahoo B, Pal A, Upadhyay P, Dutt A. Identifying cancer driver genes from functional genomics screens. Swiss Medical Weekly. 150: w20195. PMID 32083704 DOI: 10.4414/Smw.2020.20195 |
0.394 |
|
| 2020 |
Gupta S, Chaubal R, Gardi N, Pachakar S, Bhatia D, Gera P, Nair N, Joshi S, Parmar V, Thakkar P, Chitkara G, Kadam R, Gujarathi S, Oza H, Hawaldar R, ... ... Dutt A, et al. Abstract P3-05-01: Molecular effects of surgical resection on primary breast tumor Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-05-01 |
0.356 |
|
| 2019 |
Sikder S, Kumari S, Kumar M, Sen S, Singhal NB, Chellappan S, Godbole M, Chandrani P, Dutt A, Gopinath KS, Kundu TK. Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a. Oncotarget. 10: 6855-6869. PMID 31839879 DOI: 10.18632/Oncotarget.27325 |
0.339 |
|
| 2019 |
Arora R, Rekhi B, Chandrani P, Krishna S, Dutt A. Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent. Microbial Pathogenesis. 103778. PMID 31600537 DOI: 10.1016/J.Micpath.2019.103778 |
0.359 |
|
| 2019 |
Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, ... ... Dutt A, et al. Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in -Mutated Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901154. PMID 31411950 DOI: 10.1200/Jco.19.01154 |
0.442 |
|
| 2019 |
Singh S, Kumar M, Kumar S, Sen S, Upadhyay P, Bhattacharjee S, M N, Tomar VS, Roy S, Dutt A, Kundu TK. The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis. The Journal of Biological Chemistry. PMID 31366730 DOI: 10.1074/Jbc.Ra118.007265 |
0.478 |
|
| 2019 |
Noronha V, Joshi A, Patil VM, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Shah S, Yadav A, Dutt A, et al. Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C). Journal of Clinical Oncology. 37: 9001-9001. DOI: 10.1200/Jco.2019.37.15_Suppl.9001 |
0.43 |
|
| 2019 |
Nair SV, Joshi A, Patil VM, Noronha V, Sable N, Mahajan A, Dharavath B, Gardi N, Bal M, Nair D, Gupta T, Laskar S, Agarwal J, Chaturvedi P, Dutt A, et al. A phase II randomized control trial of erlotinib in combination with celecoxib in patients with operable oral squamous cell carcinoma (OSCC): Erlo-Xib Study. Journal of Clinical Oncology. 37: 6054-6054. DOI: 10.1200/Jco.2019.37.15_Suppl.6054 |
0.327 |
|
| 2018 |
Pahuja KB, Nguyen TT, Jaiswal BS, Prabhash K, Thaker TM, Senger K, Chaudhuri S, Kljavin NM, Antony A, Phalke S, Kumar P, Mravic M, Stawiski EW, Vargas D, Durinck S, ... ... Dutt A, et al. Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations. Cancer Cell. 34: 792-806.e5. PMID 30449325 DOI: 10.1016/J.Ccell.2018.09.010 |
0.431 |
|
| 2018 |
Godbole M, Togar T, Patel K, Dharavath B, Yadav N, Janjuha S, Gardi N, Tiwary K, Terwadkar P, Desai S, Prasad R, Dhamne H, Karve K, Salunkhe S, Kawle D, ... ... Dutt A, et al. Up-regulation of the kinase gene by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells. The Journal of Biological Chemistry. PMID 30337371 DOI: 10.1074/Jbc.Ra118.002894 |
0.366 |
|
| 2018 |
Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, ... ... Dutt A, et al. ERBB2 and KRAS Alterations Mediate Response to EGFR Inhibitors in Early Stage Gallbladder Cancer. International Journal of Cancer. PMID 30304546 DOI: 10.1002/Ijc.31916 |
0.476 |
|
| 2018 |
Balaji SA, Shanmugam A, Chougule A, Sridharan S, Prabhash K, Arya A, Chaubey A, Hariharan A, Kolekar P, Sen M, Ravichandran A, Katragadda S, Sankaran S, Bhargava S, Kulkarni P, ... ... Dutt A, et al. Analysis of solid tumor mutation profiles in liquid biopsy. Cancer Medicine. PMID 30264478 DOI: 10.1002/Cam4.1791 |
0.339 |
|
| 2018 |
Rajendra J, Datta KK, Ud Din Farooqee SB, Thorat R, Kumar K, Gardi N, Kaur E, Nair J, Salunkhe S, Patkar K, Desai S, Goda JS, Moiyadi A, Dutt A, Venkatraman P, et al. Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells. Oncotarget. 9: 27667-27681. PMID 29963228 DOI: 10.18632/Oncotarget.25351 |
0.32 |
|
| 2018 |
Barreto SG, Dutt A, Sirohi B, Shrikhande SV. Gallbladder cancer: a journey of a thousand steps. Future Oncology (London, England). PMID 29722272 DOI: 10.2217/Fon-2017-0576 |
0.334 |
|
| 2018 |
Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K. Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer. Lung Cancer (Auckland, N.Z.). 9: 1-11. PMID 29379323 DOI: 10.2147/LCTT.S147841 |
0.335 |
|
| 2017 |
Upadhyay P, Gardi N, Desai S, Chandrani P, Joshi A, Dharavath B, Arora P, Bal M, Nair S, Dutt A. Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 asa candidate to predict metastases. Oral Oncology. 73: 56-64. PMID 28939077 DOI: 10.1016/J.Oraloncology.2017.08.003 |
0.312 |
|
| 2017 |
Godbole M, Chandrani P, Gardi N, Dhamne H, Patel K, Yadav N, Gupta S, Badwe R, Dutt A. miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells. Cancer Biology & Therapy. 0. PMID 28876975 DOI: 10.1080/15384047.2017.1373216 |
0.314 |
|
| 2017 |
Godbole M, Tiwary K, Badwe R, Gupta S, Dutt A. Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report. Cellular Oncology (Dordrecht). PMID 28653288 DOI: 10.1007/S13402-017-0330-Z |
0.331 |
|
| 2017 |
Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy Philip D, Banavali S, Dutt A, Prabhash K. Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment. Oncotargets and Therapy. 10: 2903-2908. PMID 28652772 DOI: 10.2147/Ott.S133245 |
0.468 |
|
| 2017 |
Mittra I, Samant U, Sharma S, Raghuram GV, Saha T, Tidke P, Pancholi N, Gupta D, Prasannan P, Gaikwad A, Gardi N, Chaubal R, Upadhyay P, Pal K, Rane B, ... ... Dutt A, et al. Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. Cell Death Discovery. 3: 17015. PMID 28580170 DOI: 10.1038/Cddiscovery.2017.15 |
0.369 |
|
| 2017 |
Rajendra J, Datta K, Farooqee SBUD, Reddy R, Gardi N, Kaur E, Patkar K, Moiyadi A, Venkataraman P, Bose K, Dutt A, Gowda H, Dutt S. Abstract 5845: Identification of proteosome pathway and a novel serine threonine kinase DCLK3: Potential therapeutic targets for innately radiation resistant glioblastoma cells Cancer Research. 77: 5845-5845. DOI: 10.1158/1538-7445.Am2017-5845 |
0.378 |
|
| 2017 |
Bhatia DR, Joshi S, Chaubal R, Gera P, Kalkar P, Naeem F, Raju NM, Gardi N, Nair N, Vanmali V, Hawaldar RW, Dutt A, Badwe RA, Gupta S. Abstract 4524: The effect of acute intraoperative hypoxia in breast cancer Cancer Research. 77: 4524-4524. DOI: 10.1158/1538-7445.Am2017-4524 |
0.369 |
|
| 2017 |
Iyer PS, Gardi Nl, Ranjan M, Sahoo B, Chandrani P, Upadhyay P, Ramadwar MR, Shrikhande SV, Dutt A. Abstract 4397: Deciphering the diversity of somatic alterations andSalmonellainfection in gallbladder cancer by whole exome sequencing Cancer Research. 77: 4397-4397. DOI: 10.1158/1538-7445.Am2017-4397 |
0.35 |
|
| 2016 |
Chandrani P, Prabhash K, Choughule A, Prasad R, Sethunath V, Ranjan M, Iyer P, Aich J, Dhamne H, Iyer DN, Upadhyay P, Mohanty B, Chandna P, Kumar R, Joshi A, ... ... Dutt A, et al. Drug-sensitive FGFR3 mutations in lung adenocarcinoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 27998968 DOI: 10.1093/Annonc/Mdw636 |
0.421 |
|
| 2016 |
Rekhi B, Upadhyay P, Ramteke MP, Dutt A. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27562493 DOI: 10.1038/Modpathol.2016.144 |
0.411 |
|
| 2016 |
Upadhyay P, Gardi N, Desai S, Sahoo B, Singh A, Togar T, Iyer P, Prasad R, Chandrani P, Gupta S, Dutt A. TMC-SNPdb: an Indian germline variant database derived from whole exome sequences. Database : the Journal of Biological Databases and Curation. 2016. PMID 27402678 DOI: 10.1093/Database/Baw104 |
0.369 |
|
| 2016 |
Upadhyay P, Nair S, Kaur E, Aich J, Dani P, Sethunath V, Gardi N, Chandrani P, Godbole M, Sonawane K, Prasad R, Kannan S, Agarwal B, Kane S, Gupta S, ... ... Dutt A, et al. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. Oncotarget. PMID 27391340 DOI: 10.18632/Oncotarget.10419 |
0.386 |
|
| 2016 |
Kaur E, Sahu A, Hole AR, Rajendra J, Chaubal R, Gardi N, Dutt A, Moiyadi A, Krishna CM, Dutt S. Unique spectral markers discern recurrent Glioblastoma cells from heterogeneous parent population. Scientific Reports. 6: 26538. PMID 27221528 DOI: 10.1038/Srep26538 |
0.307 |
|
| 2016 |
Iyer P, Barreto SG, Sahoo B, Chandrani P, Ramadwar MR, Shrikhande SV, Dutt A. Non-typhoidal Salmonella DNA traces in gallbladder cancer. Infectious Agents and Cancer. 11: 12. PMID 26941832 DOI: 10.1186/S13027-016-0057-X |
0.349 |
|
| 2015 |
Ramteke MP, Patel KJ, Godbole M, Vyas M, Karve K, Choughule A, Prabhash K, Dutt A. CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations. F1000research. 4: 160. PMID 27127615 DOI: 10.12688/F1000Research.6663.2 |
0.455 |
|
| 2015 |
Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Raghuram GV, Oak N, Singh A, Chaubal R, Ramteke M, Gupta S, Dutt A. Integrated genomics approach to identify biologically relevant alterations in fewer samples. Bmc Genomics. 16: 936. PMID 26572163 DOI: 10.1186/S12864-015-2138-4 |
0.469 |
|
| 2015 |
Barreto SG, Barreto M, Chaubal R, Dutt A. The fight against cancer: Is it worthwhile? Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology. 36: 85-6. PMID 26157283 DOI: 10.4103/0971-5851.158833 |
0.365 |
|
| 2015 |
Mittra I, Khare NK, Raghuram GV, Chaubal R, Khambatti F, Gupta D, Gaikwad A, Prasannan P, Singh A, Iyer A, Singh A, Upadhyay P, Nair NK, Mishra PK, Dutt A. Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. Journal of Biosciences. 40: 91-111. PMID 25740145 DOI: 10.1007/S12038-015-9508-6 |
0.332 |
|
| 2015 |
Ramteke MP, Patel KJ, Godbole M, Vyas M, Karve K, Choughule A, Prabhash K, Dutt A. CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons F1000research. 4: 160. DOI: 10.12688/F1000Research.6663.1 |
0.449 |
|
| 2015 |
Upadhyay P, Gardi NL, Dhamne HR, Sonawane K, D'Cruz A, Nair S, Dutt A. Abstract 5161: Discovery of a matrix metalloproteinase MMP10 as a clinically relevant biomarker to predict lymph node metastasis in tongue squamous cell carcinoma Cancer Research. 75: 5161-5161. DOI: 10.1158/1538-7445.Am2015-5161 |
0.301 |
|
| 2015 |
Upadhyay P, Aich J, Sethunath V, Dani P, Kannan S, Chandrani P, Sonawane K, Agarwal B, Kane S, Nair S, Dutt A. Abstract 4811: Pro-oncogenic role of NOTCH1 in early tongue squamous cell carcinoma Cancer Research. 75: 4811-4811. DOI: 10.1158/1538-7445.Am2015-4811 |
0.304 |
|
| 2015 |
Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Gorantala RV, Oak N, Singh A, Chaubal R, Ramteke M, Gupta S, Dutt A. Abstract C154: Integrated genomics approach to identify driver alterations Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C154 |
0.48 |
|
| 2014 |
Choughule A, Sharma R, Trivedi V, Thavamani A, Noronha V, Joshi A, Desai S, Chandrani P, Sundaram P, Utture S, Jambhekar N, Gupta S, Aich J, Prabhash K, Dutt A. Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer. British Journal of Cancer. 111: 2203-4. PMID 25117816 DOI: 10.1038/Bjc.2014.401 |
0.44 |
|
| 2014 |
Barreto SG, Dutt A, Chaudhary A. A genetic model for gallbladder carcinogenesis and its dissemination. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 1086-97. PMID 24705974 DOI: 10.1093/Annonc/Mdu006 |
0.357 |
|
| 2014 |
Upadhyay P, Dwivedi R, Dutt A. Applications of Next-Generation Sequencing in Cancer Current Science. 107: 795-802. DOI: 10.18520/Cs/V107/I5/795-802 |
0.352 |
|
| 2013 |
Chougule A, Prabhash K, Noronha V, Joshi A, Thavamani A, Chandrani P, Upadhyay P, Utture S, Desai S, Jambhekar N, Dutt A. Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity. Plos One. 8: e76164. PMID 24124538 DOI: 10.1371/Journal.Pone.0076164 |
0.383 |
|
| 2013 |
Choughule A, Noronha V, Joshi A, Desai S, Jambhekar N, Utture S, Thavamanni A, Prabhash K, Dutt A. Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients. Indian Journal of Cancer. 50: 107-11. PMID 23979200 DOI: 10.4103/0019-509X.117023 |
0.436 |
|
| 2013 |
Noronha V, Prabhash K, Thavamani A, Chougule A, Purandare N, Joshi A, Sharma R, Desai S, Jambekar N, Dutt A, Mulherkar R. EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy. Plos One. 8: e61561. PMID 23620765 DOI: 10.1371/Journal.Pone.0061561 |
0.437 |
|
| 2013 |
Kumar R, Horvath A, Mazumder R, Toi M, Sato F, Pillai MR, Costa L, Carmo-Fonseca M, Knapp S, Dutt A, Gupta S, Badwe R. The Global Cancer Genomics Consortium's Second Annual Symposium: Genomics Medicine in Cancer Research Genes and Cancer. 4: 196-200. DOI: 10.1177/1947601913484582 |
0.364 |
|
| 2013 |
Liao RG, Sivachenko A, Getz G, Dutt A, Hammerman PS, Meyerson M. Abstract 963: Characterizing acquired resistance mechanisms to targeted therapy in FGFR1-amplified lung squamous cell carcinoma. Cancer Research. 73: 963-963. DOI: 10.1158/1538-7445.Am2013-963 |
0.57 |
|
| 2013 |
Nair SV, Upadhyay P, D'Cruz A, Dutt A. Abstract C125: Development of gene signature profile predicting nodal metastasis in squamous cell carcinoma of tongue. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C125 |
0.382 |
|
| 2012 |
Eswaran J, Gupta S, Dutt A, Toi M, Pillai MR, Costa L, Knapp S, Badwe R, Kumar R. The Global Cancer Genomics Consortium: Interfacing genomics and cancer medicine Cancer Research. 72: 3720-3724. PMID 22628426 DOI: 10.1158/0008-5472.Can-12-1054 |
0.373 |
|
| 2011 |
Hammerman PS, Sos ML, Ramos AH, Xu C, Dutt A, Zhou W, Brace LE, Woods BA, Lin W, Zhang J, Deng X, Lim SM, Heynck S, Peifer M, Simard JR, et al. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery. 1: 78-89. PMID 22328973 DOI: 10.1158/2159-8274.Cd-11-0005 |
0.728 |
|
| 2011 |
Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, Verhaak R, Cherniack AD, Watanabe H, Dutt A, Kwon J, Chao YS, Onofrio RC, Chiang D, Yuza Y, et al. Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer Research. 71: 7587-96. PMID 22001862 DOI: 10.1158/0008-5472.Can-11-0821 |
0.541 |
|
| 2011 |
Dutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, Chande A, Tanaka KE, Stransky N, Greulich H, Gray NS, Meyerson M. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. Plos One. 6: e20351. PMID 21666749 DOI: 10.1371/Journal.Pone.0020351 |
0.564 |
|
| 2010 |
Zhou W, Hur W, McDermott U, Dutt A, Xian W, Ficarro SB, Zhang J, Sharma SV, Brugge J, Meyerson M, Settleman J, Gray NS. A structure-guided approach to creating covalent FGFR inhibitors. Chemistry & Biology. 17: 285-95. PMID 20338520 DOI: 10.1016/J.Chembiol.2010.02.007 |
0.516 |
|
| 2009 |
Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, ... ... Dutt A, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics. 41: 1238-42. PMID 19801978 DOI: 10.1038/Ng.465 |
0.721 |
|
| 2009 |
Ramos AH, Dutt A, Mermel C, Perner S, Cho J, Lafargue CJ, Johnson LA, Stiedl AC, Tanaka KE, Bass AJ, Barretina J, Weir BA, Beroukhim R, Thomas RK, Minna JD, et al. Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer Biology & Therapy. 8: 2042-50. PMID 19755855 DOI: 10.4161/Cbt.8.21.9764 |
0.715 |
|
| 2009 |
Dutt A, Salvesen HB, Greulich H, Sellers WR, Beroukhim R, Meyerson M. Somatic mutations are present in all members of the AKT family in endometrial carcinoma. British Journal of Cancer. 101: 1218-9; author reply. PMID 19738612 DOI: 10.1038/Sj.Bjc.6605301 |
0.635 |
|
| 2009 |
Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM, Raeder MB, Sos ML, Engelsen IB, Trovik J, Wik E, Greulich H, Bø TH, Jonassen I, Thomas RK, et al. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proceedings of the National Academy of Sciences of the United States of America. 106: 4834-9. PMID 19261849 DOI: 10.1073/Pnas.0806514106 |
0.647 |
|
| 2009 |
Greulich H, Chheda M, Chen T, Tanaka K, Dutt A, Wong K, Hahn W, Meyerson M. Abstract A199: Oncogenic and drug‐sensitive ERBB2 mutations in glioblastoma Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A199 |
0.593 |
|
| 2009 |
Greulich H, Chheda M, Chen T, Tanaka K, Dutt A, Wong K, Hahn W, Meyerson M. Abstract A2: Oncogenic and drug‐sensitiveERBB2mutations in glioblastoma Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A2 |
0.595 |
|
| 2008 |
Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, ... ... Dutt A, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 455: 1069-75. PMID 18948947 DOI: 10.1038/Nature07423 |
0.598 |
|
| 2008 |
Dutt A, Salvesen HB, Chen TH, Ramos AH, Onofrio RC, Hatton C, Nicoletti R, Winckler W, Grewal R, Hanna M, Wyhs N, Ziaugra L, Richter DJ, Trovik J, Engelsen IB, et al. Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 105: 8713-7. PMID 18552176 DOI: 10.1073/Pnas.0803379105 |
0.573 |
|
| 2007 |
Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Macconnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, ... ... Dutt A, et al. High-throughput oncogene mutation profiling in human cancer. Nature Genetics. 39: 347-51. PMID 17293865 DOI: 10.1038/Ng1975 |
0.656 |
|
| 2007 |
Dutt A, Beroukhim R. Single nucleotide polymorphism array analysis of cancer. Current Opinion in Oncology. 19: 43-9. PMID 17133111 DOI: 10.1097/Cco.0B013E328011A8C1 |
0.537 |
|
| 2007 |
Thomas RK, Baker AC, DeBiasi RM, Winckler W, LaFramboise T, Lin WM, Wang M, Feng W, Zander T, MacConnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, ... ... Dutt A, et al. Erratum: Corrigendum: High-throughput oncogene mutation profiling in human cancer Nature Genetics. 39: 567-567. DOI: 10.1038/Ng0407-567A |
0.649 |
|
| 2006 |
Dutt A, Wong KK. Mouse models of lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4396s-4402s. PMID 16857817 DOI: 10.1158/1078-0432.Ccr-06-0414 |
0.446 |
|
| 2006 |
Murtaza I, Marra G, Schlapbach R, Patrignani A, Künzli M, Wagner U, Sabates J, Dutt A. A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray. Biotechnology and Applied Biochemistry. 45: 29-36. PMID 16640504 DOI: 10.1042/Ba20060044 |
0.366 |
|
| 2004 |
Dutt A, Canevascini S, Froehli-Hoier E, Hajnal A. EGF signal propagation during C. elegans vulval development mediated by ROM-1 rhomboid. Plos Biology. 2: e334. PMID 15455032 DOI: 10.1371/Journal.Pbio.0020334 |
0.604 |
|
| Show low-probability matches. |
